Author Information
Bart Jan Kullberg is a prominent researcher affiliated with the Department of Medicine and the Radboudumc Center for Infectious Diseases at Radboud University Medical Center in Nijmegen, Netherlands. His work primarily focuses on infectious diseases, with a significant emphasis on topics such as bacterial skin infections, Lyme borreliosis, and invasive fungal diseases. His contributions to the field are well-recognized within the scientific community.Research Contributions
Bart Jan Kullberg has made substantial contributions to the study of infectious diseases, as evidenced by his extensive publication record. His research includes groundbreaking work on the risks associated with various immunosuppressive therapies, such as tumor necrosis factor-alpha inhibitors and interleukin-17 inhibitors, and their potential to increase the susceptibility to infections like candidiasis. Additionally, Kullberg has explored diagnostic challenges and management strategies for Lyme borreliosis, providing valuable insights into persistent symptoms post-treatment. His work also extends to evaluating the global risk of certain medications for bacterial and viral infections.Aliases
Bart Jan Kullberg is known by various aliases in academic publications, including B.j. Kullberg, Bart‐jan Kullberg, Bart-jan Kullberg, B J Kullberg, and Bart J Kullberg, among others. These variations reflect the different ways his name has been cited across numerous research papers.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
46,178 |
| h-index |
100 |
| Paper Count |
476 |
